Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmavite Amends CholestOff Claims After FTC Joins Heart Health Hunt

This article was originally published in The Tan Sheet

Executive Summary

An attorney for Pharmavite questions federal regulators' apparent pursuit of cholesterol-lowering products after the firm satisfies a Federal Trade Commission investigation by revising marketing language for its CholestOff dietary supplement
Advertisement

Related Content

CSPI Expects Pfizer’s Centrum Claim Changes To Resonate Across Industry
CSPI Expects Pfizer’s Centrum Claim Changes To Resonate Across Industry
FDA Cheerios Warning Signals Tougher Stance On Health Claims Enforcement
Science, FDA Rule Support Centrum Cardio Claims, Wyeth Will Tell Congress
Phytosterol CHD Health Claim Expanded Interim Use Permitted By FDA
Phytosterol CHD Health Claim Expanded Interim Use Permitted By FDA

Topics

Advertisement
UsernamePublicRestriction

Register

PS103000

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel